This report offers companies, investors, policymakers, and stakeholders crucial insight into Slovakia; a country with both political and economic stability; a Eurozone member that stands out in its region for being a member of the single currency; and, for the second half of 2016, has held the rotating presidency of the Council of the European Union. Within this stable, integrated framework, Slovakia is making a name for itself in pharmaceuticals to complement its other major industries of automotives and IT.

The report features in-depth exclusive interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the Slovak healthcare and pharma sectors.